Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study

被引:70
作者
Tan, ACITL [1 ]
Brouwer, JT
Glue, P
van Leusen, R
Kauffmann, RH
Schalm, SW
de Vries, RA
Vroom, B
机构
[1] Acad Hosp, Nijmegen, Netherlands
[2] Acad Hosp, Rotterdam, Netherlands
[3] Acad Hosp, Utrecht, Netherlands
[4] Rijnstate Hosp Arnhem, Arnhem, Netherlands
[5] Leyenburg Hosp, S Gravenhage, Netherlands
[6] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
关键词
D O I
10.1093/ndt/16.1.193
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:193 / 195
页数:3
相关论文
共 5 条
[1]  
CATLIN DH, 1980, RIBAVIRIN BROAD SPEC, P83
[2]   Combination of interferon alpha and ribavirin in the treatment of hepatitis C: implications for the clinical nephrologist [J].
Fabrizi, F ;
Locatelli, F .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (09) :2079-2081
[3]  
Glue P, 1999, SEMIN LIVER DIS, V19, P17
[4]   Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions [J].
Khakoo, S ;
Glue, P ;
Grellier, L ;
Wells, B ;
Bell, A ;
Dash, C ;
Murray-Lyon, I ;
Lypnyj, D ;
Flannery, B ;
Walters, K ;
Dusheiko, GM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (06) :563-570
[5]   Interferon therapy for chronic hepatitis C in hemodialysis patients: Increased serum levels of interferon [J].
Uchihara, M ;
Izumi, M ;
Sakai, Y ;
Yauchi, T ;
Miyake, S ;
Sakai, T ;
Akiba, T ;
Marumo, F ;
Sato, C .
NEPHRON, 1998, 80 (01) :51-56